Warren Alpert Foundation Prize

The Warren Alpert Foundation Prize is awarded annually to scientist(s) whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease. The prize was established in 1987 by the late philanthropist and businessman Warren Alpert and the Warren Alpert Foundation.

The Warren Alpert Prize is given internationally and since its inception, 10 winners have gone on to win Nobel Prizes.

The prize is administered in concert with Harvard Medical School in Boston, Massachusetts and the Warren Alpert Foundation, located in Providence, Rhode Island. An annual symposium is held at Harvard Medical School each fall where the recipient(s) present their work. The prize currently includes $500,000, a citation and plaque.

Warren Alpert Foundation Prize Recipients Year Recipient(s) Citation Nationality2026Daniel Bauer, Stuart Orkin, Vijay G. Sankaran, Swee Lay Thein, John TisdaleFor enabling curative genetic therapies for individuals with the major hemoglobin disorders, Sickle Cell Disease (SCD) and beta-thalassemia. In rigorous studies over two decades, they discovered how to reactivate production of fetal hemoglobin in adults, and optimized hematopoietic cell reconstitution procedures, bringing molecularly based therapies to patients. 2025Tomas Cihlar, John Link, Wesley SundquistFor their critical contributions understanding the structure and function of the HIV capsid and to the discovery and development of lenacapavir, the first approved drug to disrupt a viral capsid and whose potency and twice yearly dosing regimen has the potential to significantly accelerate the end of the HIV epidemic. 2024Renier Brentjens, Zelig Eshhar, Carl H. June, Michel SadelainFor pioneering applications of chimeric antigen receptors to engineer T cells for adoptive immunotherapy of cancer and autoimmunity., 2023David J. LipmanFor his visionary work in the conception, design, and implementation of computational tools, databases, and infrastructure that transformed the way biological information is analyzed and accessed freely and rapidly around the world.2022Katalin Karikó, Drew Weissman, Eric Huang, Uğur Şahin, Özlem TüreciFor transformational discoveries into the biology of mRNA, for its modification for medicinal use, and for the design of mRNA-based COVID-19 vaccines.2021 Lynne Maquat, Joan Steitz For the discovery of fundamental pathways and mechanisms that ensure accurate RNA splicing and quality control of gene expression involving RNA.Prize Recipients | Warren Alpert Foundation Prize2020 Daniel Drucker, Joel Habener, Jens Juul Holst For identifying Glucagon-like peptides and leading the field with studies extending from cells to humans, culminating in the development of these peptides as therapeutic agents for treating diabetes and short bowel syndrome.2019Ed Boyden, Karl Deisseroth, Peter Hegemann, Gero MiesenböckFor pioneering work in the field of optogenetics, a revolutionary technique that uses light and genetic modification to control the activity of cells in the brain.2018 Francis Collins, Paul Negulescu, Bonnie Ramsey, Lap-Chee Tsui, Michael J. Welsh For identifying faulty gene behind devastating disease, development of precision-targeted therapies 2017 Arlene Sharpe, Harvard Medical School, Gordon J. Freeman, Dana Farber Cancer Institute, Lieping Chen, Yale University, James P. Allison, University of Texas M.D. Anderson Cancer Center, Tasuku Honjo, Kyoto University For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment. 2016 Rodolphe Barrangou, North Carolina State University, Philippe Horvath, DuPont, Jennifer Doudna, University of California, Berkeley, Emmanuelle Charpentier, Max Planck Institute for Infection Biology and Umeå University, Virginijus Šikšnys, Vilnius University Institute of Biotechnology For their remarkable contributions to the understanding of the CRISPR bacterial defense system and the revolutionary discovery that it can be adapted for genome editing 2015 Ruth Sonntag Nussenzweig and Victor Nussenzweig, NYU Langone Medical Center, Tu Youyou of the China Academy of Chinese Medical Sciences, Beijing For their pioneering discoveries in chemistry and parasitology, and their personal commitment to translating these discoveries into effective chemotherapeutic and vaccine-based approaches to controlling malaria 2014 Oleh Hornykiewicz, Medical University of Vienna, Roger A. Nicoll, University of California, San Francisco, Solomon H. Snyder, Johns Hopkins School of Medicine For seminal contributions to our understanding of neurotransmission and neurodegeneration. 2013 David Botstein, Princeton University, Ronald W. Davis, Stanford University School of Medicine, and David Hogness, Stanford University School of Medicine For their seminal contributions to the concepts and methods of creating a genetic map in the human, and of positional cloning, leading to the identification of thousands of human disease genes and ushering in the era of human genetics. 2012 Julian Adams, Infinity Pharmaceuticals, Kenneth C. Anderson, Dana–Farber Cancer Institute, Alfred L. Goldberg, Harvard Medical School, and Paul G. Richardson, Dana–Farber Cancer Institute For the discovery, preclinical and clinical development of bortezomib to FDA approval and front line therapy for the treatment of patients with multiple myeloma. 2011 Alain Carpentier, Hôpital Européen Georges-Pompidou, and Robert Langer, Massachusetts Institute of Technology For their application of bioengineering principles to fundamental improvements in human health. 2009-2010 Howard Green, Harvard Medical School For development of methodologies for the expansion and differentiation of human keratinocyte stem cells for permanent skin restoration in victims of extensive burns. 2008 Lloyd Aiello, Joslin Diabetes Center For the discovery, characterization and implementation of laser panretinal photocoagulation, which is used to treat proliferative diabetic retinopathy 2007 Harald zur Hausen and Lutz Gissmann, German Cancer Research Center For work leading to the development of a vaccine against human papillomavirus. 2006 Dennis Slamon, UCLA; Robert Weinberg, MIT; Michael Shepard, Receptor BioLogix, Inc; and Axel Ullrich, Center for Molecular Medicine, For their work in identifying HER-2/neu as an oncogene and development of the anti-HER-2/neu monoclonal antibody Herceptin for breast cancer therapy. 2005 M. Judah Folkman, Harvard Medical School and Boston Children's Hospital For discovering tumor angiogenesis, and for pioneering work in the development of antiangiogenic therapies for cancer. 2004 Susan Band Horwitz, Albert Einstein College of Medicine For her seminal contributions to the understanding of how the antitumor agent Taxol kills cancer cells. 2003 Sidney Pestka, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, David Goeddel, Tularik, Inc., and Charles Weissmann, Imperial College School of Medicine, London For purification and characterization of interferon alpha; cloning of the human interferon alpha gene and mass production of recombinant interferon alpha for cancer treatment and treatment of hepatitis C. 2002 Alfred Sommer, Johns Hopkins University Bloomberg School of Public Health For epidemiologic insight into the effects of Vitamin A deficiency, and the resulting reduction in childhood mortality worldwide. 2001 Eugene Braunwald, Harvard Medical School, and Barry Coller, Rockefeller University School of Medicine. For work in cardiac physiology and pathophysiology, leading to the use of monoclonal antibodies to platelet surface antigens in antithrombotic therapy. 2000 David Baltimore, California Institute of Technology, Brian Druker, Oregon Health Sciences University, Nicholas Lydon, Amgen, Inc., Alex Matter, Novartis Pharma AG, and Owen Witte, University of California, Los Angeles. For Development of Abl kinase inhibitors for use in the treatment of chronic myelogenous leukemia 1999 Michael S. Brown and Joseph L. Goldstein, University of Texas Southwestern Medical School, Akira Endo (biochemist), Tokyo Noko University For Development of HMG CoA reductase inhibitors. 1998 K. Frank Austen, Harvard Medical School For elucidating the role of leukotrienes in asthma. 1997 Robert C. Gallo, University of Maryland School of Medicine, and Luc Montagnier, Queens College, New York For isolation of the Human Immunodeficiency Virus. 1996 Leo Sachs, Weizmann Institute of Science, and Donald Metcalf, University of Melbourne For discovery of blood cell growth factors. 1995 John A. Clements, University of California, San Francisco For discovery of lung surfactant, and development of synthetic lung surfactant therapy for Infant Respiratory Distress Syndrome. 1994 J.R. Warren, Royal Perth Hospital, and Barry J. Marshall, University of Virginia For linking gastric ulcers to the H. pylori bacterium. 1993 Stuart H. Orkin, Harvard Medical School. For genetic and molecular mechanisms of Βeta-Thalassemia and other blood disorders. 1992 Roscoe O. Brady, National Institutes of Health For treatment for Gaucher's Disease. 1991 David W. Cushman and Miguel A. Ondetti, Bristol Myers-Squibb For ACE inhibitor therapy for hypertension and heart failure. 1990 No prize awarded. 1989 Yuet Wai Kan, University of California, San Francisco For prenatal genetic screening for blood diseases. 1988 Louis Kunkel, Harvard Medical School For discovery of the gene associated with a major form of muscular dystrophy. 1987 Kenneth Murray (biologist), University of Edinburgh For development of a vaccine against Hepatitis B.

Warren Alpert Foundation Prize

Bron en licentie